NuPotential Company
NuPotential produces dedifferentiated cell lines suitable for re-differentiation into multiple lineages and somatic cell nuclear transfer. Its cells are used in therapies that reverse the debilitating effects of diabetes, stroke, heart disease, Alzheimer's disease, Parkinson's disease, and other afflictions, as well as in drug discovery tool applications.
Technology:
Cancer
Industry:
Geroscience
Headquarters:
Baton Rouge, Louisiana, United States
Zip:
1-10
Founded Date:
2004-01-01
Employees Number:
1-10
Investors Number:
725000
Total Funding:
$10M to $50M
Estimated Revenue:
$10M to $50M
Last Funding Date:
Venture - Series Unknown
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership